BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19506956)

  • 1. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
    Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
    Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
    J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy.
    Sorbero ME; Dick AW; Beckjord EB; Ahrendt G
    Ann Surg Oncol; 2009 Jun; 16(6):1597-605. PubMed ID: 19330381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
    Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
    Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
    Güth U; Myrick ME; Viehl CT; Weber WP; Lardi AM; Schmid SM
    Eur J Surg Oncol; 2012 Apr; 38(4):296-301. PubMed ID: 22305274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
    Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
    J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.
    Miller ME; Czechura T; Martz B; Hall ME; Pesce C; Jaskowiak N; Winchester DJ; Yao K
    Ann Surg Oncol; 2013 Dec; 20(13):4113-20. PubMed ID: 23868655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences of healthy inner city women and the surgical treatment of early stage breast cancer.
    Fontana V; Castro T; Polynice A
    Am Surg; 2007 Mar; 73(3):215-21. PubMed ID: 17375774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's decision-making roles regarding contralateral prophylactic mastectomy.
    Nekhlyudov L; Bower M; Herrinton LJ; Altschuler A; Greene SM; Rolnick S; Elmore JG; Harris EL; Liu A; Emmons KM; Fletcher SW; Geiger AM
    J Natl Cancer Inst Monogr; 2005; (35):55-60. PubMed ID: 16287886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer.
    Stucky CC; Gray RJ; Wasif N; Dueck AC; Pockaj BA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():330-7. PubMed ID: 20853055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
    Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
    J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
    Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
    Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.